Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumour features and responses to treatment with dihydroorotate dehydrogenase inhibitors
Open Access
- 27 June 2025
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Abstract
Background: Alteration in metabolic activities is a critical step in cancer progression. Myriad metabolic-based therapy options are increasingly being proposed for human tumours. However, emerging evidence highlights interpatient metabolic heterogeneity and underscores the importance of metabolic phenotyping in cancer treatment. Objectives: To investigate metabolic heterogeneity in cutaneous squamous cell carcinoma (cSCC) and its impact on cSCC characteristics and treatment responses. Methods: We applied combined proteomic and bioenergetic analyses to patient samples representing various stages of cSCC, ranging from precancerous actinic keratosis to metastatic cSCC. To investigate the functional impacts of the identified metabolic heterogeneities on tumour characteristics and treatment responses, we used patient-derived tumour cell (PDC) and patient-derived xenograft (PDX) models by transplanting tumour cells and freshly resected patient tumours into immunocompromised mice. Results: Three subgroups with low, medium and high metabolic scores, respectively, were identified across all stages of carcinogenesis. Functional analyses indicated that, in both models (PDC and PDX), the sensitivities of tumours to leflunomide, an inhibitor of dihydroorotate dehydrogenase (DHODH), were inversely correlated with their metabolic scores and directly correlated with DHODH protein expression level. Moreover, DHODH overexpression in nonresponding groups rendered them sensitive to leflunomide. Conclusions: The findings demonstrate the relevance of metabolic profiling and scoring in the design of therapeutic approaches targeting the bioenergetic vulnerabilities of tumours and suggest DHODH as a promising therapeutic target in the low metabolic score subgroup of cSCC.Keywords
Funding Information
- Fondation ARC pour la Recherche sur le Cancer
- Institutional
- Inserm
This publication has 45 references indexed in Scilit:
- Energy metabolism in skin cancers: A therapeutic perspectiveBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2017
- Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cellsBiochimie, 2017
- Metabolic Heterogeneity in Human Lung TumorsCell, 2016
- Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012JAMA Dermatology, 2015
- Emerging concepts in bioenergetics and cancer research: Metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapyThe International Journal of Biochemistry & Cell Biology, 2015
- Sentiment analysis algorithms and applications: A surveyAin Shams Engineering Journal, 2014
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cellsThe International Journal of Biochemistry & Cell Biology, 2011
- Antitumor activity of brequinar sodium (Dup-785) against human head and neck squanmous cell carcinoma xenograftsCancer Letters, 1990
- Pharmacokinetics of Brequinar sodium (NSC 368390) in patients with solid tumors during a phase I studyEuropean Journal of Cancer and Clinical Oncology, 1989